Friday, November 13, 2020
Leading Human Immunology and Infectious Disease Experts to Join UM School of Medicine's Institute of Human Virology
Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine at the University of Maryland School of Medicine (UMSOM) and Co-Founder & Director of the UMSOM’s Institute of Human Virology (IHV), announced today that a team of leading scientists in human immunology, virology and stem cell biology, led by Lishan Su, PhD, joined the Institute of Human Virology on October 1 with academic appointments in the UMSOM Department of Pharmacology. As part of the Maryland E-Nnovation Initiative Fund (MEIF) to recruit top research faculty and a donation to the Institute of Human Virology from the Charles Gordon Estate, Dr. Su will be receiving the Charles Gordon Smith Endowed Professorship for HIV Research. Dr. Su will also head the Institute of Human Virology's Division of Virology, Pathogenesis and Cancer.
Friday, November 13, 2020
UM School of Medicine and School of Pharmacy Researchers Identify Promising New Compounds to Potentially Treat Novel Coronaviruses
Researchers at the University of Maryland School of Medicine (UMSOM) and School of Pharmacy (UMSOP) have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19. The compounds disrupt the functioning of a protein complex inside human cells that the researchers discovered is critical for the replication and survival of coronaviruses. This finding could lead to the development of new broad-spectrum antiviral drugs that target viruses such as influenza, Ebola and coronaviruses, according to a new study published today in the Proceedings of the National Academy of Sciences (PNAS) journal.
Tuesday, November 10, 2020
Highly Successful Faculty Recruiting Initiative Attracts Dozens of Preeminent Teams of NIH-Funded Scientists to the UMSOM
University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today the conclusion of the Special Trans-Disciplinary Recruitment Award Program (STRAP), a highly successful faculty initiative that brought dozens of top researchers-physician-scientists and biomedical scientists to the UMSOM faculty. This program will be succeeded by a new Dean's challenge initiative that will focus on large program project and center grants, known as the LGAP Initiative (Large Grant Award Program).
Thursday, October 29, 2020
UM School of Medicine Hosts 25th Annual Conference On Advancing School Mental Health with Focus on Covid-19 Pandemic
The National Center for School Mental Health at the University of Maryland School of Medicine (UMSOM) will be hosting its virtual 25th Annual Conference on Advancing School Mental Health on October 29, 2020, from 12:00 PM to 3:00 PM (ET). This year’s theme focuses on equitable and effective school mental health and will include a focus on COVID-19 mental health issues including children experiencing grief from the loss of a loved one during the pandemic and stressors from disruptions in learning.
Friday, October 23, 2020
Landmark Study Suggests Malaria-Preventive Drugs Dramatically Reduce Infections and Improve Health of School Children
With nearly half of the world’s population at risk for life-threatening malaria infections, University of Maryland School of Medicine researchers and their colleagues identified an important public health measure to control the disease. Use of preventive antimalarial treatments reduces by half the number of malaria infections among schoolchildren, according to a new analysis published today in The Lancet Global Health. Preventive treatment also reduces cases of anemia among schoolchildren by 15 percent and is associated with improved learning in children older than 10 years.
Thursday, October 22, 2020
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM). Aspirin takers were less likely to be placed in the intensive care unit (ICU) or hooked up to a mechanical ventilator, and they were more likely to survive the infection compared to hospitalized patients who were not taking aspirin, The study, published today in the journal Anesthesia and Analgesia, provides “cautious optimism,” the researchers say, for an inexpensive, accessible medication with a well-known safety profile that could help prevent severe complications.
Wednesday, October 21, 2020
UM School of Medicine Postdoctoral Fellow Awarded Prestigious AAAS Science and Technology Policy Fellowship
Ryan Richardson, PhD, Postdoctoral Fellow, Department of Pharmacology, at the University of Maryland School of Medicine (UMSOM) was awarded a highly prestigious American Association for the Advancement of Science (AAAS) Science & Technology Policy Fellowship (STPF), placing him at the National Institutes of Health (NIH)’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative for a year.
Tuesday, October 20, 2020
UMSOM Launches New Dean's Challenge Award Program Aimed at Securing Large NIH Program / Center Grants
University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, today announced the launch of a major new initiative, called the Large Grant Acceleration Program, or “LGAP,” to further enhance the UMSOM’s upward trajectory as a global leader in biomedical research and discovery.
Tuesday, October 20, 2020
Congratulations to our 163 faculty physicians for being named 2020 “Top Docs” by Baltimore Magazine!
Doctors who practice at the University of Maryland Medical Center University and Midtown Campuses, all members of the University of Maryland School of Medicine faculty, were recognized as "Top Doctors" in the October 2020 issue of Baltimore magazine.
Tuesday, October 06, 2020
UM School of Medicine Scientist Receives Prestigious NIH Director's New Innovator Award
$2.3 million Award Targeted for “High-Risk, High Reward” Research that Aims to Understand Contribution of Blood Flow to Brain Plasticity